Hemochromatosis drugs

Hemochromatosis is when there is an excessive accumulation of iron in the body. Different types include primary, secondary, and neonatal hemochromatosis.

by J Poole 2024Bacon BR. Hemochromatosis: discovery of the HFE gene. Missouri medicine. 2024;109(2): . Hemochromatosis (Iron Overload): Causes, Symptoms

Drugs Filters Recent cases Popular cases Relevant cases hemochromatosis is a disease of iron accumulation

hemochromatosis, also called classic hereditary hemochromatosis. Iron chelators are drugs that bind to the excess iron in the body

The two non-hereditary forms of hemochromatosis are secondary hemochromatosis and neonatal hemochromatosis medication that will lower the

Hereditary hemochromatosis is a type of hemochromatosis These drugs tightly bind iron and remove it from the body, lowering iron stores.

by MD Park 2024Hereditary Hemochromatosis, The Medicine Forum: Vol. We discuss the clinical work up involved in making the diagnosis of non-HFE hemochromatosis and the

The top development phase for Hemochromatosis is preclinical with four drugs in that stage. The Hemochromatosis pipeline has eight drugs in development by companies and 0 by universities/ institutes. Some of the companies in the Hemochromatosis pipeline products market are: Sirnaomics, Silence Therapeutics and Vifor Pharma Management.

It also analyses Hemochromatosis therapeutic drugs key players involved in developing key drugs. Pipeline Development Activities The report covers the detailed information of collaborations, acquisition and merger, licensing along with a thorough therapeutic assessment of emerging Hemochromatosis drugs. Hemochromatosis Report Insights